â– PHYSIOLOGICAL CORE: Sertoli cells (sustentacular cells) are the specialized supportive cells located within the seminiferous tubules that coordinate spermatogenesis.
â– PARACRINE REWIRINGS:
1. FSH Stimulation: Follicle-Stimulating Hormone (FSH) binds to Gs-coupled receptors on Sertoli cells, activating cAMP signaling pathways.
2. Androgen-Binding Protein (ABP): Stimulates the synthesis and secretion of ABP, which is secreted into the tubular lumen to bind testosterone.
3. High Local Testosterone: This sequesters testosterone, achieving the high local concentrations required for spermatogenesis.
4. Inhibin B: Synthesizes inhibin B, which acts as a selective feedback inhibitor of pituitary FSH secretion.
5. Blood-Testis Barrier: Form tight junctions with adjacent Sertoli cells to isolate developing germ cells from the systemic circulation.
â– PROGNOSTIC CRITERIA & TIMELINE:
Patient outcome scales correlate heavily with diagnostic staging at presentation, age, pre-existing comorbidities, and biological markers of cellular dividing rates.
â– SURGICAL COMPASS & ANATOMICAL CORRELATION:
Dissection lines must respect established fascial boundaries to prevent neurovascular traction injuries and secure excellent diagnostic margins.
[HY-BOARD-1189]
🌟 Dynamic Clinical Key:
Sertoli cell dysfunction can present with low sperm counts and low inhibin B levels, despite normal systemic testosterone. On biopsy, sperm development is halted because the blood-testis barrier and high local androgen concentrations are compromised. Regularly reassess clinical parameters to adjust long-term therapy. Verify landmarks dynamically with gentle palpation and specialized intraoperative markers.